M&A / Deals Asahi Kasei acquires German company Aicuris Pharmaceutical TechnologyAsahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company.M&A / DealsRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) Pharmaceutical Technology Asahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company. M&A / DealsRead full story Post navigation Previous: Trump executive order lifts psychedelics biotechsNext: Italy leads the way on child genetic disease diagnosis Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026